Rticc
Seleccione idioma:  
Buscar:
RTICC 2013
Programas RTICC
Agenda
Seguimiento cientifico
Sobre la RTICC 2013-2016 » Work Packages
 
INTEGRATION AND JOINT PROGRAM OF ACTIVITIES

The list of Scientific Programs contemplated in this proposal for a new cancer RETIC sponsored by ISCIII for the period 2013-2016 represents a natural evolution of the previously experienced vertical research Lines and horizontal Platforms held in the context of the Cooperative Cancer research networks active in Spain since 2003.

Indeed, the Executive committees of the prior RTICC editions have always endeavored to review and modify their research programs with an aim at improving the quantity and quality of the cooperative cancer research performed in the RTICCs as well as increasing the ability of the RTICC networked groups to collaborate and compete at the international level. With similar intent, the ISCIII has now included in the current RETIC call a number of additional requisites, not previously contemplated in previous RTICCs, such as the predominantly traslational nature of the research to be performed, the emphasis on bigger size and productivity of the networked groups, and the requirement for a minimum 50% of clinical research groups in the final roster of the network.

Taking into account the above mentioned need for quality improvements and the new selection criteria contained in the ISCIII call, recent deliberations of the Executive Committee of the currently active RTICC produced in January 2012 a suggested list of 8 separate Scientific Programs that is basically coincident with the set of Programs listed for all potential cancer RETIC proposals in the call for new RETIC applications published by SCIII in the BOE issue of March2012.

After defining the specific Programs to be included in the proposal, the CE also designed a detailed calendar and procedure for selection of the most appropriate PI candidates for those Programs in a competitive process open not only to previous members of RTICC but also to PI candidates from other scientific organizations or networks. Interestingly, an important number of groups from the currently active RTICC became fused into a single new group inorder to present their candidacy to this new cancer RETIC. In parallel, the EC also elected a Coordinator for each proposed scientific Program who was put in charge of piloting and managing the preparation of the specific research programs and work packages and defining the expected contributions and matching budgets assigned to each participating group. All these preparations and selection processes were completed at the end of May, and a final list of programs, coordinators and group PIs was released by the EC after its meeting of may 28th.

The list of Programs, Work packages, Coordinator and Group PIs included in this new RETIC on cancer is as follows:

Bienvenida
Organización
Presentación
Objetivos
Work Packages
Intranet
Directorio
Coordinación RTICC
Noticias
03/03/2017 | Otras reuniones
13/11/2016 | Otras reuniones
Publicaciones
RD12/0036/0053
Adherence to capecitabine in preoperative treatment of stage II and III rectal cancer: do we need to worry?
Font R, Espinas JA, Layos L, Martinez Villacampa M, Capdevila J, Tobeña M, Pisa A, Pericay C, Lezcano C, Fort E, Cardona I, Berga N, Solà J, Borras JM
Ann Oncol  2017.  4.  831-835.  PMID: 28327898. 

RD12/0036/0053
Understanding variations in the use of hypofractionated radiotherapy and its specific indications for breast cancer: A mixed-methods study.
Prades J, Algara M, Espinàs JA, Farrús B, Arenas M, Reyes V, García-Reglero V, Cambra MJ, Rubio E, Anglada L, Eraso A, Pedro A, Fuentes-Raspall MJ, Tuset V, Solà J, Borras JM
Radiother Oncol  2017.  1.  22-28.  PMID: 28236538. 

RD12/0036/0053
Current developments in cancer care: including the patients' perspective-3rd European Roundtable Meeting (ERTM) June 17, 2016, Berlin, Germany.
Ortmann O, Rösler W, Helbig U, participants of the ERTM.
J Cancer Res Clin Oncol  2017.  4.  673-676.  PMID: 27988842. 

RD12/0036/0005
Snail1-expressing fibroblasts as a source of paracrine signals in colon cancer tumors
Herrera A, Herrera M, Alba-Castellón L, Silva J, García V, Loubat J, Alvarez-Cienfuegos A, García JM, Rodríguez R, Gil B, Citores MJ, Larriba MJ, Casal JI, García de Herreros A, Bonilla F, Peña C
  2014. 
Grupos colaboradores: RD12/0036/0005 , RD12/0036/0041

RD12/0036/0005
The Epithelial-to-Mesenchymal Transition (EMT), a Particular Case.
Cebrià-Costa JP, Millanes-Romero A, de Herreros AG, Peiró S
Mol Cell Oncol  2014.  2.  e960770.  PMID: 27308335. 

RD12/0036/0005
Snail1 controls cooperative cell plasticity during metastasis.
Baulida J
Oncoscience  2015.  11.  898-9.  PMID: 26697515. 

RD12/0036/0005
Lysyl oxidase-like 2 (LOXL2) oxidizes trimethylated lysine 4 in histone H3.
Herranz N, Dave N, Millanes-Romero A, Pascual-Reguant L, Morey L, Díaz VM, Lórenz-Fonfría V, Gutierrez-Gallego R, Jerónimo C, Iturbide A, Di Croce L, García de Herreros A, Peiró S
FEBS J  2016.  23.  4263-4273.  PMID: 27735137. 

RD12/0036/0005
Pharmacological Approaches in an Experimental Model of Non-Small Cell Lung Cancer: Effects on Tumor Biology.
Mateu-Jimenez M, Fermoselle C, Rojo F, Mateu J, Peña R, Urtreger AJ, Diament MJ, Joffé ED, Pijuan L, Herreros AG, Barreiro E
Curr Pharm Des  2016.  34.  5300-5310.  PMID: 27339432. 
Grupos colaboradores: RD12/0036/0005 , RD12/0036/0051

RD12/0036/0005
Snail1-Dependent Activation of Cancer-Associated Fibroblast Controls Epithelial Tumor Cell Invasion and Metastasis.
Alba-Castellón L, Olivera-Salguero R, Mestre-Farrera A, Peña R, Herrera M, Bonilla F, Casal JI, Baulida J, Peña C, García de Herreros A
Cancer Res  2016.  21.  6205-6217.  PMID: 27503928. 
Grupos colaboradores: RD12/0036/0005 , RD12/0036/0041

RD12/0036/0005
Antisense non-coding RNAs and regulation of gene transcription.
Beltran M, García de Herreros A
Transcription  2016.  2.  39-43.  PMID: 26985653. 

ISCII
ISCII
 
Ministerio de Economia y Competitividad
Descargar
Red Temática Investigación Cooperativa Sanitaria
Rticc 2012
Logotipos
 
ISCII
Red Temática Investigación Cooperativa en Cáncer (RTICC)
Centro de Investigación Cáncer - Campus Miguel de Unamuno - 37007 - Salamanca
(+34) 923294803 - sec.rticc[arroba]usal.es
|
|
|
|
 
Sobre la RTICC Programas RTICC Ofertas de empleo y Agenda Seguimiento científico
Red Temática de Investigación Cooperativa en Cáncer · © Copyright 2013 · sec.rticc[arrroba]usal.es · diseño web: detrazos
RSS